BIO-key International (NASDAQ:BKYI) Issues FY 2023 Earnings Guidance

BIO-key International (NASDAQ:BKYI) issued an update on its FY 2023 earnings guidance on Monday morning. The company provided earnings per share guidance of -11.450–11.450 for the period. The company issued revenue guidance of $9.1 million-$9.1 million, compared to the consensus revenue estimate of $10.0 million. BIO-key International also updated its Q4 2023 guidance to -5.540–5.540 EPS.

BIO-key International Price Performance

Shares of BKYI stock traded up $0.06 during midday trading on Monday, reaching $2.16. 45,206 shares of the company were exchanged, compared to its average volume of 157,179. BIO-key International has a 12 month low of $1.74 and a 12 month high of $15.30. The company has a market cap of $1.64 million, a P/E ratio of -0.13 and a beta of 0.41. The company’s 50 day moving average price is $1.98 and its two-hundred day moving average price is $3.64. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.59 and a current ratio of 1.30.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.